Pre-HF™ Solutions

The saliva In Vitro Diagnostics (IVD) testing solution is designed to meet different demands of multiple industry segments. The Saliveomix™ platform is engineered to enable multi-product solution, with opportunities as Companion Diagnostic Device (CDx) solution with dedicated treatment.

The Saliveomix™ platform incorporates patent protected novel biomarkers, coupled with established saliva proteomics detection technology, producing highly accurate early risk of Heart Failure detection products.

The novel biomarkers were originated from research study during the past 10+ years. The panel of biomarkers has since evolved with continuous study and development, in conjunction to technological and data science progression. 

Early Risk of Heart Failure Detection
1/5
1/5
1/5